Procter & Gamble Health Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Milind Thatte
Chief executive officer
₹32.2m
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 6.6yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 5.4yrs |
Recent management updates
Recent updates
Procter & Gamble Health (NSE:PGHL) Is Due To Pay A Dividend Of ₹60.00
Nov 15
Risks To Shareholder Returns Are Elevated At These Prices For Procter & Gamble Health Limited (NSE:PGHL)
Nov 05Procter & Gamble Health (NSE:PGHL) Has Announced A Dividend Of ₹60.00
Sep 28Procter & Gamble Health (NSE:PGHL) Has Announced A Dividend Of ₹60.00
Aug 27Earnings Not Telling The Story For Procter & Gamble Health Limited (NSE:PGHL)
Jun 08Weak Statutory Earnings May Not Tell The Whole Story For Procter & Gamble Health (NSE:PGHL)
Feb 14Procter & Gamble Health (NSE:PGHL) Has Announced That It Will Be Increasing Its Dividend To ₹50.00
Sep 29Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 10Procter & Gamble Health's (NSE:PGHL) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 27A Look At The Fair Value Of Procter & Gamble Health Limited (NSE:PGHL)
Mar 30We Think The Compensation For Procter & Gamble Health Limited's (NSE:PGHL) CEO Looks About Right
Nov 17Procter & Gamble Health (NSE:PGHL) Has Announced That Its Dividend Will Be Reduced To ₹11.50
Oct 23Procter & Gamble Health's (NSE:PGHL) Dividend Will Be Reduced To ₹11.50
Oct 09Procter & Gamble Health's (NSE:PGHL) Problems Go Beyond Weak Profit
Feb 16Do Procter & Gamble Health's (NSE:PGHL) Earnings Warrant Your Attention?
Oct 04Here's Why I Think Procter & Gamble Health (NSE:PGHL) Is An Interesting Stock
May 10Would Procter & Gamble Health Limited (NSE:PGHL) Be Valuable To Income Investors?
Mar 23Is Weakness In Procter & Gamble Health Limited (NSE:PGHL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
Mar 02Should You Be Adding Procter & Gamble Health (NSE:PGHL) To Your Watchlist Today?
Jan 31Here's What Procter & Gamble Health Limited's (NSE:PGHL) Shareholder Ownership Structure Looks Like
Jan 10
Is Procter & Gamble Health Limited (NSE:PGHL) An Attractive Dividend Stock?
Dec 19Is Procter & Gamble Health Limited's (NSE:PGHL) Latest Stock Performance A Reflection Of Its Financial Health?
Dec 01CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹2b |
| Jun 30 2024 | ₹32m | ₹32m | ₹2b |
| Mar 31 2024 | n/a | n/a | ₹2b |
| Dec 31 2023 | n/a | n/a | ₹2b |
| Sep 30 2023 | n/a | n/a | ₹2b |
| Jun 30 2023 | ₹25m | ₹25m | ₹2b |
| Mar 31 2023 | n/a | n/a | ₹2b |
| Dec 31 2022 | n/a | n/a | ₹2b |
| Sep 30 2022 | n/a | n/a | ₹2b |
| Jun 30 2022 | ₹39m | ₹39m | ₹2b |
| Mar 31 2022 | n/a | n/a | ₹2b |
| Dec 31 2021 | n/a | n/a | ₹1b |
| Sep 30 2021 | n/a | n/a | ₹2b |
| Jun 30 2021 | ₹32m | ₹32m | ₹2b |
| Mar 31 2021 | n/a | n/a | ₹2b |
| Dec 31 2020 | n/a | n/a | ₹2b |
| Sep 30 2020 | n/a | n/a | ₹2b |
| Jun 30 2020 | ₹17m | ₹26m | ₹2b |
| Mar 31 2020 | n/a | n/a | ₹2b |
| Dec 31 2019 | n/a | n/a | ₹2b |
| Sep 30 2019 | n/a | n/a | ₹1b |
| Jun 30 2019 | n/a | n/a | ₹1b |
| Mar 31 2019 | n/a | n/a | ₹1b |
| Dec 31 2018 | ₹20m | ₹13m | ₹1b |
Compensation vs Market: Milind's total compensation ($USD381.84K) is about average for companies of similar size in the Indian market ($USD354.64K).
Compensation vs Earnings: Milind's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Milind Thatte (55 yo)
6.6yrs
Tenure
₹32,234,000
Compensation
Mr. Milind Vasant Thatte, M.Pharm.Sci., M.B.A., has been Managing Director and Executive Director of Procter & Gamble Health Limited (formerly known as Merck Limited) since April 1, 2018. Mr. Thatte had a...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | 6.6yrs | ₹32.23m | no data | |
| CFO, Finance Head & Executive Director | 1.6yrs | ₹24.94m | no data | |
| Non-Executive Independent Chairman of the Board | 40.8yrs | ₹2.33m | 0.036% ₹ 30.8m | |
| Non-Executive Independent Director | 3yrs | ₹2.20m | no data | |
| Non-Executive Independent Director | 9.8yrs | ₹2.18m | no data | |
| Non-Executive Director | 5.4yrs | no data | no data | |
| Non-Executive Director | 1.6yrs | no data | no data |
5.4yrs
Average Tenure
61.5yo
Average Age
Experienced Board: PGHL's board of directors are considered experienced (5.4 years average tenure).